tiprankstipranks
Biogen (DE:IDP)
XETRA:IDP
Germany Market
IDP
Biogen
RESEARCH TOOLSreports

Biogen (IDP) Ratios

6 Followers

Biogen Ratios

DE:IDP's free cash flow for Q2 2026 was $0.57. For the 2026 fiscal year, DE:IDP's free cash flow was decreased by $ and operating cash flow was $0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.87 2.68 1.35 2.00 2.99
Quick Ratio
 1.26 2.03 0.90 1.26 2.58
Cash Ratio
 0.33 0.90 0.43 0.31 1.04
Solvency Ratio
 0.11 0.20 0.20 0.14 0.32
Operating Cash Flow Ratio
 0.73 0.66 0.52 0.45 0.42
Short-Term Operating Cash Flow Coverage
 3.60 27.42 1.64 10.31 0.00
Net Current Asset Value
$ -5.93B$ -2.21B$ -3.88B$ -5.19B$ -1.37B
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.24 0.24 0.27 0.27
Debt-to-Equity Ratio
 0.44 0.38 0.40 0.50 0.49
Debt-to-Capital Ratio
 0.31 0.28 0.28 0.33 0.33
Long-Term Debt-to-Capital Ratio
 0.28 0.26 0.21 0.31 0.32
Financial Leverage Ratio
 1.70 1.61 1.68 1.81 1.83
Debt Service Coverage Ratio
 1.52 9.17 1.36 5.65 11.78
Interest Coverage Ratio
 4.47 7.63 9.95 8.49 11.72
Debt to Market Cap
 0.25 0.26 0.28 0.19 0.16
Interest Debt Per Share
 58.50 49.04 47.22 52.42 47.22
Net Debt to EBITDA
 4.23 1.27 1.42 2.65 0.90
Profitability Margins
Gross Profit Margin
67.71%70.47%76.12%74.24%77.61%
EBIT Margin
11.19%22.07%24.00%19.14%29.67%
EBITDA Margin
16.80%31.60%30.96%24.17%34.77%
Operating Profit Margin
12.79%19.14%25.74%21.32%28.40%
Pretax Profit Margin
8.61%14.29%19.70%13.18%35.33%
Net Profit Margin
8.39%13.18%16.87%11.81%29.95%
Continuous Operations Profit Margin
8.39%13.18%16.87%11.81%29.11%
Net Income Per EBT
97.51%92.29%85.63%89.54%84.77%
EBT Per EBIT
67.31%74.65%76.54%61.83%124.41%
Return on Assets (ROA)
2.60%4.39%5.82%4.33%12.41%
Return on Equity (ROE)
4.52%7.08%9.76%7.85%22.74%
Return on Capital Employed (ROCE)
4.52%7.20%11.06%8.96%13.58%
Return on Invested Capital (ROIC)
4.28%6.62%8.79%7.97%11.19%
Return on Tangible Assets
7.21%9.39%13.74%9.47%17.97%
Earnings Yield
2.56%5.01%7.33%3.10%7.57%
Efficiency Ratios
Receivables Turnover
 5.28 5.25 5.18 4.68 4.76
Payables Turnover
 7.95 6.71 5.45 6.28 4.64
Inventory Turnover
 1.35 1.34 0.94 1.00 1.69
Fixed Asset Turnover
 3.07 2.95 2.74 2.64 2.75
Asset Turnover
 0.31 0.33 0.34 0.37 0.41
Working Capital Turnover Ratio
 2.08 2.60 3.62 1.98 2.02
Cash Conversion Cycle
 294.20 288.20 392.19 383.96 213.29
Days of Sales Outstanding
 69.18 69.46 70.50 77.93 76.65
Days of Inventory Outstanding
 270.90 273.16 388.71 364.14 215.38
Days of Payables Outstanding
 45.89 54.43 67.02 58.11 78.74
Operating Cycle
 340.09 342.63 459.21 442.07 292.03
Cash Flow Ratios
Operating Cash Flow Per Share
 19.49 15.03 19.74 10.69 9.53
Free Cash Flow Per Share
 20.10 13.98 17.27 8.54 7.87
CapEx Per Share
 0.61 1.05 2.47 2.15 1.65
Free Cash Flow to Operating Cash Flow
 1.03 0.93 0.87 0.80 0.83
Dividend Paid and CapEx Coverage Ratio
 32.06 14.33 7.99 4.97 5.76
Capital Expenditure Coverage Ratio
 32.06 14.33 7.99 4.97 5.76
Operating Cash Flow Coverage Ratio
 0.34 0.32 0.43 0.21 0.21
Operating Cash Flow to Sales Ratio
 0.29 0.22 0.30 0.16 0.14
Free Cash Flow Yield
9.10%7.94%11.29%3.30%2.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 38.88 19.89 13.65 32.25 13.21
Price-to-Sales (P/S) Ratio
 3.28 2.63 2.30 3.81 3.96
Price-to-Book (P/B) Ratio
 1.73 1.41 1.33 2.53 3.00
Price-to-Free Cash Flow (P/FCF) Ratio
 10.99 12.59 8.86 30.30 35.17
Price-to-Operating Cash Flow Ratio
 11.33 11.71 7.75 24.20 29.07
Price-to-Earnings Growth (PEG) Ratio
 -0.85 -0.95 0.34 -0.52 0.13
Price-to-Fair Value
 1.73 1.41 1.33 2.53 3.00
Enterprise Value Multiple
 23.76 9.60 8.86 18.40 12.28
Enterprise Value
 39.70B 29.76B 26.54B 43.73B 43.43B
EV to EBITDA
 23.76 9.60 8.86 18.40 12.28
EV to Sales
 3.99 3.03 2.74 4.45 4.27
EV to Free Cash Flow
 13.37 14.51 10.55 35.39 37.96
EV to Operating Cash Flow
 13.79 13.50 9.23 28.27 31.37
Tangible Book Value Per Share
 -11.23 17.64 3.75 1.50 39.84
Shareholders’ Equity Per Share
 127.61 124.45 114.73 102.28 92.21
Tax and Other Ratios
Effective Tax Rate
 0.02 0.08 0.14 0.10 0.18
Revenue Per Share
 67.35 66.88 66.41 67.97 70.02
Net Income Per Share
 5.65 8.82 11.20 8.02 20.97
Tax Burden
 0.98 0.92 0.86 0.90 0.85
Interest Burden
 0.77 0.65 0.82 0.69 1.19
Research & Development to Revenue
 0.20 0.20 0.26 0.27 0.26
SG&A to Revenue
 0.26 0.25 0.25 0.25 0.23
Stock-Based Compensation to Revenue
 0.01 0.03 0.03 0.03 0.02
Income Quality
 6.89 1.71 1.76 1.33 0.47
Currency in USD